The NADase CD38 is a central regulator in gouty inflammation and a novel druggable therapeutic target

Elucidating the Onset of Cross-protective Immunity after Intranasal Vaccination with the Attenuated African Swine Fever Vaccine Candidate BA71ΔCD2

A Single Cell RNA Sequence Atlas of the Early Drosophila Larval Eye

Male autism spectrum disorder is linked to brain aromatase disruption by prenatal BPA in multimodal investigations and 10HDA ameliorates the related mouse phenotype (BPA)

Super-silencer perturbation by EZH2 and REST inhibition leads to large loss of chromatin interactions and reduction in cancer growth [RNA-seq]

Super-silencer perturbation by EZH2 and REST inhibition leads to large loss of chromatin interactions and reduction in cancer growth

Mycoplasma feriruminatoris transcriptome

Hepatic BMAL1 and HIF1a regulate a time-dependent hypoxic response and their absence leads to Hepatopulmonary Syndrome

RGS4 controls airway hyperresponsiveness through GAP-independent mechanisms

Comparative physiological and transcriptomic profiling reveals the characteristics of tissue　tolerance mechanisms in Japanese rice landrace under salt stress

Metabolism-dependent secondary effect of anti-MAPK cancer therapy on DNA repair [glutamine]

Metabolism-dependent secondary effect of anti-MAPK cancer therapy on DNA repair [RNA-seq]

Metabolism-dependent secondary effect of anti-MAPK cancer therapy on DNA repair [MAPK inhibitors]

Metabolism-dependent secondary effect of anti-MAPK cancer therapy on DNA repair

Metabolism-dependent secondary effect of anti-MAPK cancer therapy on DNA repair [QuantSeq_BRAF]

Metabolism-dependent secondary effect of anti-MAPK cancer therapy on DNA repair [QuantSeq_Q_siCTU2]

Metabolism-dependent secondary effect of anti-MAPK cancer therapy on DNA repair [RNAseq_siRNA_MAPKi]

Low dose ruxolitinib plus cyclosporine to treat murine immune-mediated bone marrow failure

Toxicicty of ruxolitinib in normal mice

Combination therapy with low dose ruxolitinib and cyclosporine in murine immune bone marrow failure